Douglas Lane & Associates’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-616
| Closed | -$213K | – | 226 |
|
|
2021
Q2 | $213K | Buy |
+616
| New | +$213K | ﹤0.01% | 220 |
|
|
2019
Q1 | – | Sell |
-726
| Closed | -$218K | – | 218 |
|
|
2018
Q4 | $218K | Hold |
726
| – | – | 0.01% | 196 |
|
|
2018
Q3 | $257K | Buy |
+726
| New | +$257K | 0.01% | 187 |
|
|
2018
Q2 | – | Sell |
-824
| Closed | -$226K | – | 196 |
|
|
2018
Q1 | $226K | Sell |
824
-50
| -6% | -$13.7K | ﹤0.01% | 188 |
|
|
2017
Q4 | $278K | Buy |
874
+20
| +2% | +$6.36K | 0.01% | 182 |
|
|
2017
Q3 | $267K | Sell |
854
-15
| -2% | -$4.69K | 0.01% | 188 |
|
|
2017
Q2 | $236K | Buy |
869
+65
| +8% | +$17.7K | 0.01% | 192 |
|
|
2017
Q1 | $220K | Sell |
804
-197
| -20% | -$53.9K | 0.01% | 198 |
|
|
2016
Q4 | $284K | Sell |
1,001
-300
| -23% | -$85.1K | 0.01% | 192 |
|
|
2016
Q3 | $407K | Sell |
1,301
-95
| -7% | -$29.7K | 0.01% | 180 |
|
|
2016
Q2 | $338K | Buy |
1,396
+36
| +3% | +$8.72K | 0.01% | 189 |
|
|
2016
Q1 | $354K | Buy |
+1,360
| New | +$354K | 0.01% | 186 |
|